Progression of Retinopathy with Intensive versus Conventional Treatment in the Diabetes Control and Complications Trial
References (17)
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
N Engl J Med
(1993)Design and methodologic considerations for the feasibility phase
Diabetes
(1986)The Diabetes Control and Complications Trial DCCT: Update
Diabetes Care
(1990)- The DCCT Research Group. Implementation of Treatment Protocols in the Diabetes Control and Complications Trial:...
Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10
Ophthalmology
(1991)Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12
Ophthalmology
(1991)Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1
Arch Ophthalmol
(1985)- Early Treatment Diabetic Retinopathy Study (ETDRS). Manual of Operations. Available from the National Technical...
There are more references available in the full text version of this article.
Cited by (457)
Cumulative HbA1c exposure as a CVD risk in patients with type 2 diabetes: A post hoc analysis of ACCORD trial
2023, Diabetes Research and Clinical PracticeDeveloping and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy
2023, Ophthalmology ScienceNanotechnology in tissue engineering for diabetes management
2023, Nanostructured Materials for Tissue EngineeringLipids, atherosclerosis, and microvascular disease: Translating basic science into pharmacotherapeutics
2023, Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic MedicineIncidence and prevalence of diabetic retinopathy in the Greenlandic Inuit: A register-based study
2022, Diabetes Epidemiology and ManagementTreatment Options for Diabetic Macular Edema
2024, International Ophthalmology Clinics
Sponsored by the Division of Diabetes, Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institutes of Health, Bethesda, Maryland, through cooperative agreements and a research contract, and by the National Heart, Lung and Blood Institute, the National Eye Institute, and the National Center for Research Resources, Bethesda, Maryland.
- *
A complete listing of the Diabetes Control and Complications Trial Research Group can be found in Arch Ophthalmol 1995;113:36-51.
Copyright © 1995 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights reserved.